New York, NY, United States of America

Gwendalyn J Randolph

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Icahn School of Medicine at Mount Sinai, Massachusetts Institute of Technology, Sanofi Pasteur Vaxdesign Corporation. Active years: 2010-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwendalyn J Randolph. Retrieved from https://idiyas.com/inventor/gwendalyn-j-randolph

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0



Average Co-Inventor Count = 9.4

ph-index = 2

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gwendalyn J Randolph

Introduction: Gwendalyn J Randolph is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to various fields.

Latest Patents: Gwendalyn J Randolph's latest patents include a revolutionary medical device for early disease detection and a sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Gwendalyn J Randolph has established herself as a leading figure in the innovation landscape, with numerous patents and inventions to her name.

Collaborations: Throughout her career, Gwendalyn J Randolph has collaborated with top research institutions, universities, and companies to bring her innovative ideas to life, fostering a culture of creativity and progress.

Conclusion: Gwendalyn J Randolph's dedication to pushing the boundaries of innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and creators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…